title: Screening ABL1 kinase domain mutations in patients with de novo Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL).
authors.affiliation: a Department of Hematology, Hematologic Research Laboratory , West China Hospital of Sichuan University , Chengdu , P.R. China.
authors.forename: He
authors.initials: H
authors.lastname: Li
authors.affiliation: a Department of Hematology, Hematologic Research Laboratory , West China Hospital of Sichuan University , Chengdu , P.R. China.
authors.forename: Wanhua
authors.initials: W
authors.lastname: Zhang
authors.affiliation: a Department of Hematology, Hematologic Research Laboratory , West China Hospital of Sichuan University , Chengdu , P.R. China.
authors.forename: Dongni
authors.initials: D
authors.lastname: Yi
authors.affiliation: b Department of Laboratory Medicine , West China Hospital of Sichuan University , Chengdu , P.R. China.
authors.forename: Yuanxin
authors.initials: Y
authors.lastname: Ye
authors.affiliation: c West China School of Medicine , Sichuan University , Chengdu , P.R. China.
authors.forename: Xueqiu
authors.initials: X
authors.lastname: Xiao
mesh_terms: D016044:Fusion Proteins, bcr-abl / Q000235:genetics*; D006801:Humans; D009154:Mutation; D010677:Philadelphia Chromosome; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma; D047428:Protein Kinase Inhibitors
chemical_list: D047428:Protein Kinase Inhibitors; D016044:Fusion Proteins, bcr-abl